NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS

NeoGenomics, Inc. (the "Company") (NASDAQ: NEO) , a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it has finalized a civil settlement with the Department of Justice ("DOJ") on behalf of the Office of Inspector General of the U.S. Departmen...